GlobalData on MSN9h
Junshi partners LEO Pharma for toripalimab distribution in Europe
Shanghai Junshi Biosciences and its subsidiary TopAlliance Biosciences are set to enter a collaboration with LEO Pharma to ...
FiercePharma9h
Leo bags EU rights to Junshi's Loqtorzi, putting marketing muscle behind PD-1 launch
Leo Pharma has stepped up to commercialize toripalimab in Europe, inking a deal with Shanghai Junshi Biosciences to secure ...
The Pharma Letter12h
Junshi partners with LEO Pharma for toripalimab in Europe
China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...
BioWorld3h
BioWorld, Deals and M&A
Gilead Sciences Inc. is moving further into inflammatory diseases in a potential $1.7 billion deal with Leo Pharma A/S around a preclinical oral signal transduction and activator of transcription 6 ...
BioSpace19h
2025 Investment to Swing Toward I&I, Obesity, More: Experts
As the year gets underway, analysts and biotech executives highlight cell therapy’s pivot from oncology to autoimmune ...
LEO Weekly7h
Notes from the Road: Revelations of a Lone Louisville Lyft Driver – Part I
In this first installment of a two-part series, freelance writer Charlie Cy provides an overview and window into his world ...
Indiatimes8h
Nifty Pharma
What does Nifty Pharma represent? Tracks the performance of pharmaceutical companies in India, comprising leading pharmaceutical stocks listed on the National Stock Exchange (NSE), reflecting trends ...
Indiatimes3h
Mankind Pharma Share Price
Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,07,283.90 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...